These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35108519)

  • 1. An oncogenic enhancer encodes selective selenium dependency in AML.
    Eagle K; Jiang Y; Shi X; Li M; Obholzer NP; Hu T; Perez MW; Koren JV; Kitano A; Yi JS; Lin CY; Nakada D
    Cell Stem Cell; 2022 Mar; 29(3):386-399.e7. PubMed ID: 35108519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Oncogenic Super Enhancers in MYC-Dependent AML Using a Small Molecule Activator of NR4A Nuclear Receptors.
    Call SG; Duren RP; Panigrahi AK; Nguyen L; Freire PR; Grimm SL; Coarfa C; Conneely OM
    Sci Rep; 2020 Feb; 10(1):2851. PubMed ID: 32071334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SEPHguarding acute myeloid leukemia.
    Gupta M; Will B
    Cell Stem Cell; 2022 Mar; 29(3):350-352. PubMed ID: 35245465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of functional transposable element enhancers in acute myeloid leukemia.
    Zeng Y; Cao Y; Halevy RS; Nguyen P; Liu D; Zhang X; Ahituv N; Han JJ
    Sci China Life Sci; 2020 May; 63(5):675-687. PubMed ID: 32170627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia.
    Kiehlmeier S; Rafiee MR; Bakr A; Mika J; Kruse S; Müller J; Schweiggert S; Herrmann C; Sigismondo G; Schmezer P; Krijgsveld J; Gröschel S
    Leukemia; 2021 Nov; 35(11):3127-3138. PubMed ID: 33911178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective Requirement of MYB for Oncogenic Hyperactivation of a Translocated Enhancer in Leukemia.
    Smeenk L; Ottema S; Mulet-Lazaro R; Ebert A; Havermans M; Varea AA; Fellner M; Pastoors D; van Herk S; Erpelinck-Verschueren C; Grob T; Hoogenboezem RM; Kavelaars FG; Matson DR; Bresnick EH; Bindels EM; Kentsis A; Zuber J; Delwel R
    Cancer Discov; 2021 Nov; 11(11):2868-2883. PubMed ID: 33980539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEO1 is regulated by PRL-3 and mediates its oncogenic properties in acute myelogenous leukemia.
    Chong PS; Zhou J; Cheong LL; Liu SC; Qian J; Guo T; Sze SK; Zeng Q; Chng WJ
    Cancer Res; 2014 Jun; 74(11):3043-53. PubMed ID: 24686170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m
    Weng H; Huang H; Wu H; Qin X; Zhao BS; Dong L; Shi H; Skibbe J; Shen C; Hu C; Sheng Y; Wang Y; Wunderlich M; Zhang B; Dore LC; Su R; Deng X; Ferchen K; Li C; Sun M; Lu Z; Jiang X; Marcucci G; Mulloy JC; Yang J; Qian Z; Wei M; He C; Chen J
    Cell Stem Cell; 2018 Feb; 22(2):191-205.e9. PubMed ID: 29290617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis.
    Rasmussen KD; Jia G; Johansen JV; Pedersen MT; Rapin N; Bagger FO; Porse BT; Bernard OA; Christensen J; Helin K
    Genes Dev; 2015 May; 29(9):910-22. PubMed ID: 25886910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML.
    Duy C; Teater M; Garrett-Bakelman FE; Lee TC; Meydan C; Glass JL; Li M; Hellmuth JC; Mohammad HP; Smitheman KN; Shih AH; Abdel-Wahab O; Tallman MS; Guzman ML; Muench D; Grimes HL; Roboz GJ; Kruger RG; Creasy CL; Paietta EM; Levine RL; Carroll M; Melnick AM
    Cancer Discov; 2019 Jul; 9(7):872-889. PubMed ID: 31076479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrinsically disordered Meningioma-1 stabilizes the BAF complex to cause AML.
    Riedel SS; Lu C; Xie HM; Nestler K; Vermunt MW; Lenard A; Bennett L; Speck NA; Hanamura I; Lessard JA; Blobel GA; Garcia BA; Bernt KM
    Mol Cell; 2021 Jun; 81(11):2332-2348.e9. PubMed ID: 33974912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 is required for oncogenic
    Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
    Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Super-enhancer profiling identifies novel critical and targetable cancer survival gene LYL1 in pediatric acute myeloid leukemia.
    Fang F; Lu J; Sang X; Tao YF; Wang JW; Zhang ZM; Zhang YP; Li XL; Xie Y; Wu SY; Chu XR; Li G; Wu D; Chen YL; Yu JJ; Jia SQ; Feng CX; Tian YY; Li ZH; Ling J; Hu SY; Pan J
    J Exp Clin Cancer Res; 2022 Jul; 41(1):225. PubMed ID: 35842703
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yao X; Tan J; Lim KJ; Koh J; Ooi WF; Li Z; Huang D; Xing M; Chan YS; Qu JZ; Tay ST; Wijaya G; Lam YN; Hong JH; Lee-Lim AP; Guan P; Ng MSW; He CZ; Lin JS; Nandi T; Qamra A; Xu C; Myint SS; Davies JOJ; Goh JY; Loh G; Tan BC; Rozen SG; Yu Q; Tan IBH; Cheng CWS; Li S; Chang KTE; Tan PH; Silver DL; Lezhava A; Steger G; Hughes JR; Teh BT; Tan P
    Cancer Discov; 2017 Nov; 7(11):1284-1305. PubMed ID: 28893800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
    Bahr C; von Paleske L; Uslu VV; Remeseiro S; Takayama N; Ng SW; Murison A; Langenfeld K; Petretich M; Scognamiglio R; Zeisberger P; Benk AS; Amit I; Zandstra PW; Lupien M; Dick JE; Trumpp A; Spitz F
    Nature; 2018 Jan; 553(7689):515-520. PubMed ID: 29342133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis.
    Feder K; Edmaier-Schröger K; Rawat VPS; Kirsten N; Metzeler K; Kraus JM; Döhner K; Döhner H; Kestler HA; Feuring-Buske M; Buske C
    Leukemia; 2020 Apr; 34(4):1027-1037. PubMed ID: 31758089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
    Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
    Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models.
    Minzel W; Venkatachalam A; Fink A; Hung E; Brachya G; Burstain I; Shaham M; Rivlin A; Omer I; Zinger A; Elias S; Winter E; Erdman PE; Sullivan RW; Fung L; Mercurio F; Li D; Vacca J; Kaushansky N; Shlush L; Oren M; Levine R; Pikarsky E; Snir-Alkalay I; Ben-Neriah Y
    Cell; 2018 Sep; 175(1):171-185.e25. PubMed ID: 30146162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancer remodeling drives MLL oncogene-dependent transcriptional dysregulation in leukemia stem cells.
    Pan F; Iwasaki M; Wu W; Jiang Y; Yang X; Zhu L; Zhao Z; Cleary ML
    Blood Adv; 2023 Jun; 7(11):2504-2519. PubMed ID: 36705973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.